Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ginkgo Bioworks Holdings Inc DNA

Alternate Symbol(s):  DNABW

Chemicals Specialty Chemicals
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration... see more

Recent & Breaking News (NYSE:DNA)

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

PR Newswire 10 days ago

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing

PR Newswire 11 days ago

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation

PR Newswire November 5, 2024

NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture

PR Newswire September 24, 2024

Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology

PR Newswire September 18, 2024

Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology

PR Newswire September 17, 2024

Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement

PR Newswire September 4, 2024

Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

PR Newswire August 30, 2024

Ginkgo Bioworks Reports Second Quarter 2024 Financial Results

PR Newswire August 8, 2024

Ginkgo Bioworks to Hold Special Meeting of Shareholders

PR Newswire August 2, 2024

Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Presentation

PR Newswire August 1, 2024

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA)

PR Newswire July 23, 2024

Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals

PR Newswire July 16, 2024

Ginkgo Bioworks to Participate in Two Conferences in May

PR Newswire May 15, 2024

Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan

PR Newswire May 14, 2024

Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE

PR Newswire May 13, 2024

Ginkgo Bioworks Reports First Quarter 2024 Financial Results

PR Newswire May 9, 2024

GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener

PR Newswire May 7, 2024

Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

PR Newswire May 6, 2024

Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation

PR Newswire May 2, 2024